IPO Monitor
Subscribe Login Login About Us Contact Us Help
Latest IPO News (beta)

[ All Markets | U.S. | Canada | Europe | China ]


Exagen Diagnostics to Present at The Piper Jaffray 30th Annual Heathcare Conference

Leader in autoimmunity testing to present at upcoming investor conference
[ GlobeNewswire at 2018-11-13 06:30:00 ]


AIM3 Ventures Inc. Announces Closing of Initial Public Offering


[ GlobeNewswire at 2018-11-13 05:46:00 ]


BRIEF-Medalist Diversified REIT Inc now sees IPO of up to 350,000 shares of common stock priced to be between $9.00 and ...

Medalist Diversified REIT Inc: * MEDALIST DIVERSIFIED REIT INC NOW SEES IPO OF UP TO 350,000 SHARES OF COMMON STOCK PRICED TO BE BETWEEN $9.00 AND $11.00 PER SHARE - SEC FILING. * MEDALIST DIVERSIFIED REIT INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 700,000 COMMON SHARES PRICED TO BE BETWEEN $9.00 AND $11.00 PER SHARE Source text for Eikon: https://bit.ly/2RSj8PT.
[ Fidelity at 2018-11-13 03:39:54 ]


Tencent-backed Chinese travel firm slashes HK IPO size amid weak markets

Tencent Holdings-backed online Chinese travel firm Tongcheng-Elong launched a far smaller than expected Hong Kong IPO of up to $233 million on Tuesday, amid a weak stock market and a string of poor performances from recent listings in the city.
[ Fidelity at 2018-11-12 21:22:42 ]


Palantir Has a $20 Billion Valuation and a Big Problem: It Keeps Losing Money

The Silicon Valley unicorn, a data-analysis giant that’s inching toward an IPO, has been run like a scrappy startup, including lavish perks. CEO Alex Karp is now under pressure to remake the business, including bringing an end to what’s known inside the company as “Palantir Entitlement Syndrome.”
[ WSJ.com at 2018-11-12 19:02:58 ]


SoftBank Is Asking for Too Much for Its Mobile Unit

Japan's SoftBank is famous for paying sky-high prices for its overseas acquisitions. It will have difficulty persuading investors to do the same for its domestic mobile unit. The technology conglomerate said Monday that the Tokyo Stock Exchange had approved the initial public offering of up to nearly 37% of the unit, known as SoftBank Corp. SoftBank is looking to raise as much as $23 billion, which it could then plow into more tech unicorns, through its near- $100 billion Vision...
[ Fidelity at 2018-11-12 17:36:11 ]


Record Biotech IPO May Be Worth the $7 Billion

The biggest biotech IPO on record is coming soon, and the $7 billion price tag isn't as crazy as it sounds. Moderna Therapeutics, one of the most closely watched biotechs, filed a registration statement with the Securities and Exchange Commission last week to raise up to $500 million. Moderna is valued at about $7 billion based on its last fundraising.
[ Fidelity at 2018-11-12 14:12:52 ]


Eton Pharma Prices IPO

Eton Pharmaceuticals(ETON), a specialty pharmaceutical company, said after markets closed on Monday that it has priced its initial public offering of 3.6 million shares of its common stock at $6 per share. All of the shares are being offered by Eton. Eton has also granted the underwriter a 45-day option to buy an additional 0.5 million shares at the IPO price.
[ Fidelity at 2018-11-12 13:58:21 ]


Eton Pharmaceuticals Announces Pricing of Initial Public Offering


[ GlobeNewswire at 2018-11-12 13:52:00 ]


Eventbrite stock dips after first earnings report since IPO

Eventbrite Inc.(EB) shares dipped almost 5% in extended trading after the company reported better-than-expected sales growth in its first quarterly earnings report as a public company Monday afternoon. The online-ticketing service reported a net loss of $35.6 million, or $1.24 a share, on sales of $73.6 million, up from $50.7 million a year ago. Nearly half of Eventbrite's (EB) losses, more than $15 million, were credited to stock-based compensation, which can be especially heavy in the...
[ Fidelity at 2018-11-12 13:20:43 ]


BRIEF-Firsthand Technology Value Fund Holding Revasum Files Prospectus For IPO

Firsthand Technology Value Fund Inc(SVVC) : * FIRSTHAND TECHNOLOGY VALUE FUND HOLDING REVASUM FILES PROSPECTUS FOR INITIAL PUBLIC OFFERING. * FIRSTHAND TECHNOLOGY VALUE FUND (SVVC) - REVASUM PLANS TO SELL CHESS DEPOSITORY INTERESTS IN AUSTRALIA, WITH EACH CDI REPRESENTING ONE SHARE OF REVASUM STOCK. * Firsthand Technology Value Fund Inc (SVVC) - REVASUM'S FILING INDICATES A PRICE OF AU$2.00 PER CDI.
[ Fidelity at 2018-11-12 13:20:40 ]


Activist Investor Icahn Says VMWare Shares Worth $300/Share Amid Dell Offer - VMW Down 2%

VMWare(VMW) shares should be worth $300 per share, activist investor Carl Icahn said in a letter, as Dell plans to pay $21.7 billion in cash and stock to buy back VMWare (VMW) shares, returning it to the exchange without an initial public offering.
[ Fidelity at 2018-11-12 12:44:17 ]


Record Biotech IPO May Be Worth the $7 Billion

The biggest biotech IPO on record is coming soon, and the $7 billion price tag isn't as crazy as it sounds. Moderna Therapeutics, one of the most closely watched biotechs, filed a registration statement with the Securities and Exchange Commission last week to raise up to $500 million. Moderna is valued at about $7 billion based on its last fundraising.
[ Fidelity at 2018-11-12 09:27:47 ]


Revasum Gets Closer to IPO


[ GlobeNewswire at 2018-11-12 08:00:00 ]


SoftBank Is Asking for Too Much for Its Mobile Unit

Japan's SoftBank is famous for paying sky-high prices for its overseas acquisitions. It will have difficulty persuading investors to do the same for its domestic mobile unit. The technology conglomerate said Monday that the Tokyo Stock Exchange had approved the initial public offering of up to nearly 37% of the unit, known as SoftBank Corp. SoftBank is looking to raise as much as $23 billion, which it could then plow into more tech unicorns, through its near- $100 billion Vision...
[ Fidelity at 2018-11-12 05:03:02 ]


Analyst Actions: Osmotica Pharmaceuticals Initiated by RBC at Outperform, Price Target at $17/Share

Osmotica Pharmaceuticals(OSMT) received an investment rating of outperform Monday from RBC Capital Markets as the firm initiated coverage of the biopharmaceutical company's shares at $17 each, nearly double the stock's Friday closing price of $8.60. The stock went public in October at an initial-public-offering price of $7 per share and has traded in a range of $7.30 to $9.90 since then.
[ Fidelity at 2018-11-12 04:23:44 ]


Japan's SoftBank steps closer to transformation with mammoth mobile IPO

SoftBank Group Corp(SFTBF) has won approval to conduct a 2.4 trillion yen initial public offering of its domestic telecoms business, in a deal that will seal the group's transformation into a top global technology investor.
[ Fidelity at 2018-11-12 01:38:35 ]


SoftBank's mobile unit launches $21 billion IPO: filing

SoftBank Group Corp's domestic telecoms unit on Monday received approval to list on the Tokyo Stock Exchange in an initial public offering worth 2.4 trillion yen, a regulatory filing showed, one of the biggest IPOs ever. The unit, SoftBank Corp, will list on the Tokyo Stock Exchange on Dec. 19, the filing with the Ministry of Finance showed on Monday.
[ Fidelity at 2018-11-11 22:29:31 ]


SAP to buy software firm Qualtrics in $8 billion deal

Utah-based Qualtrics had filed for IPO last month. SAP SE (SAP) has agreed to purchase Qualtrics International Inc. for $8 billion in cash, the companies announced Sunday. Qualtrics, a Utah-based software company, had filed for an initial public offering in October hoping to raise about $200 million.
[ Fidelity at 2018-11-11 15:50:37 ]


BRIEF-New Fortress Energy Llc Files For IPO Of Up To $100 Mln

NEW FORTRESS ENERGY LLC: * NEW FORTRESS ENERGY LLC FILES FOR IPO OF UP TO $100 MILLION – SEC FILING. * NEW FORTRESS ENERGY LLC INTEND TO APPLY TO LIST CO'S CLASS A SHARES ON NASDAQ GLOBAL SELECT MARKET UNDER THE SYMBOL “NFE. * NEW FORTRESS ENERGY LLC SAYS MORGAN STANLEY AND BARCLAYS ARE UNDERWRITERS TO IPO.
[ Fidelity at 2018-11-09 14:58:24 ]


More IPO News >>    

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2018 IPO Monitor. All rights reserved